Dr. Ziai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080
Education & Training
- Yale-New Haven Medical CenterFellowship, Molecular Genetic Pathology, 2011 - 2013
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematopathology, 2010 - 2011
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- Rutgers New Jersey Medical SchoolClass of 2006
Certifications & Licensure
- CA State Medical License 2010 - 2025
- CT State Medical License 2011 - 2013
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Hematology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 77 citationsA mutation in separase causes genome instability and increased susceptibility to epithelial cancerJennifer L. Shepard, James F. Amatruda, David Finkelstein, James Ziai, K. Rose Finley
Genes & Development. 2007-01-01 - 3162 citationsTGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Sanjeev Mariathasan, Shannon J. Turley, Dorothee Nickles, Alessandra Castiglioni, Kobe C. Yuen
Nature. 2018-02-22 - 506 citationsAtezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinomaJeffrey Wallin, Johanna C. Bendell, Roel Funke, Mario Sznol, Konstanty Korski
Nature Communications. 2016-08-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: